Review: Cardiovascular effect of garlic (Allium sativum);Revisión: Efectos cardiovasculares del ajo (Allium sativum)

Archivos Latinoamericanos de Nutricion

Volumn 50, Issue 3, 2000, Pages 219-229

  Gómez, L Jacinto García ^a   Sánchez Muniz, Francisco J ^a  

^a NONE

Author keywords

Blood pressure; Cholesterol; Composition; Fibrinolysis; Garlic; Lipoprotein; Platelet aggregation; Triglycerides

Indexed keywords

LIPID;

ANIMAL; ARTERIOSCLEROSIS; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHEMISTRY; GARLIC; HUMAN; HYPERTENSION; MEDICINAL PLANT; PHYTOTHERAPY; REVIEW; THROMBOCYTE AGGREGATION; VASCULAR RESISTANCE;

ANIMALS; ARTERIOSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; GARLIC; HUMANS; HYPERTENSION; LIPIDS; PHYTOTHERAPY; PLANTS, MEDICINAL; PLATELET AGGREGATION; VASCULAR RESISTANCE;

EID: 0040199937     PISSN: 00040622     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (88)

1. Block E. The chemistry of garlic and onions. Sci Am 1985;252:114-119.
2. Block E. Antithrombotic agent of garlic: A lesson from 5000 years of folk medicine. In: Steiner RP, editor. Folk Medicine: The Art and the Science. Washington, DC: American Chemical Society. 1986:125-137.
3. Srivastava KC, Bordiov A, Verma K. Garlic (Allium sativum) for disease prevention. South African J Sci 1995;91:68-77.
4. Fenwick GR, Hanley AB. The genus Allium. Part 1. CRC Crit Rev Food Sci Nutr 1985;22:199-271.
5. Hanly AB, Fenwick GR. Cultivated alliums. J Plant Foods 1985;6:211-238.
6. Moyers S. Garlic in health, history, and world cuisine. St. Petersburg, USA: Suncoast Press, 1996.
7. Souci SW, Fachmann W, Krant H. Food Composition and Nutrition Tables. Stuttgart: Medpharm, 1994.
8. Ministerio de Sanidad y Consumo. Secretaría General Técnica. Carretero Baeza ML, Gómez Vazquez MD revisión y coordinación. Tablas de Composición de Alimentos Españoles 1995.
9. Lancaster JE, McCallion BJ, Shaw ML. The levels of precursors, the S-alk(en)yl-L-cysteine sulphoxides during the growth of the onion (Allium cepa L.). J Sci Food Agric 1984;35:415-421.
10. Mazza G. Functional Foods. Biochemical & Processing Aspects. Lancaster, Basel: Technomic Publishing CO., Inc. 1998:204-233.
11. Freeman GG. Distribution of flavour components in onion (Allium cepa l.), leek (Allium porrum) and garlic (Allium sativum). J Sci Food Agric 1975;26:471-481.
12. Malkeja AN,Bailey JM. Antiplatelet constituents of garlic and onions. Agent Actions 1990;29:360-363.
13. Freeman GG, Whenham RJ. Changes in onion (Allium cepa L.) flavour components resulting from some postharvest processes. J Sci Food Agric 1974;25:499-515.
14. Freeman GG, Whenham RJ. Nature and origin of volatile flavour components of onions and related species. Flavours 1976;910:222-229
15. Breu W, Dorch W. Allium cepa L (onion): Chemistry analysis and pharmacology. Econ Med Plant Res 1994;6:116-147.
16. Sumiyoshi H, Wargovich MJ. Garlic (Allium sativum): A review of its relationship to cancer. Asia Pacific J Pharmacol 1989;4:133-140.
17. Bobbol A, Augusti KT, Joseph PK. Hypolipidemic effects of onion oil and garlic oil in ethanol-fed rats. Indian J Biochem Biophys 1984;21, 211-213.
18. Chi MS, Koh ET, Stewart TI. Effects of garlic on lipid metabolism in rats fed cholesterol or lard. J Nutr 1982;112:241-248.
19. Kamanna VS, Cahdrasekhara N. Hypocholesterolemic activity of different fractions of garlic. Indian J Med Res 1984;79:580-583.
20. Pushpendran CK, Devasagayam TPA, Banerji A, Eapen J. Cholesterol-lowering effect of allicin in suckling rats. Indian J Exp Biol 1980;18:858-861.
21. Srivastava M, Swarn N, Kapoor NK. Effect of hypocholesterolemic agents of plant origin on catecholamine biosynthesis in normal and cholesterol fed rabbits. J Biosci 1984;3:277-282.
22. Ismail MF, Gad MZ, Hamdy MA. Study of the hypolipidemic properties of pectin, garlic and ginseng in hypercholesterolemic rabbits. Pharmacol Res 1999;39:157-166.
23. Basksh R, Chughatai MID. Influence of garlic on serum cholesterol, serum triglycerides, serum total lipids and serum glucose in human subjects. Nahrung 1984;28:159-163.
24. Bordia AK, Bansai HC, Arora SK, Rathore AS, Ranawat RVS, Singh SV. Effects of the essential oil (active principle) of garlic on serum cholesterol, plasma fibrinogen, whole blood coagulation time and fibrinolytic activity in alimentary lipaemia. J Assoc Physicians India 1974;22:267-270.
25. Bhushan S, Sharma SP, Agrawall S, Indraycin A, Seth P. Effects of garlic on normal blood cholesterol levels. Indian J Physiol Pharmacol 1979;23:211-214.
26. Augusti KT. Hypocholesterolaemic effect of garlic (Allium sativum). Indian J Exp Biol 1977;15:489-490.
27. Damnau F. The use of garlic concentrate in vascular hypertension. Med Record 1941;153:249-251.
28. Sucur M. Effect of garlic on serum lipids and lipoproteins in patients sufferingfrom hyperlipoproteinernia. Diabetol Croatica 1980;9:323-338.
29. Ernst E, Weihmayr T, Matrai A. Garlic and blood lipids. Br Med J 1985;291:139.
30. Warshafsky S, Kamer RS, Sivak SI. Effect of garlic on total serum cholesterol: ameta-analysis. Ann Intern Med 1993;119. 599-615.
31. Silagy C, Neil A. Garlic as a lipid lowering agent-a metaanalysis, J R Coll Physicians London 1994;28:39-45.
32. McCrindle BW, Helden E, Conner WT. Garlic extract therapy in children with hypercholesterolemia. Arch Pediatr Adolesc Med 1998;152:1089-94.
33. Isaacsohn JL, Moser M, Stein EA, Dudley K, Liskov E, Black HR. Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial. Arch Intern Med 1998;158:1189-94.
34. Simons LA, Balasubramiam S, Von Konigsmark M, Parfitt A. Simons J, Peters W. On the effect of garlic on plasma lipids and lipoproteins in mild hypercholesterolaemia. Atherosclerosis 1995;113:219-225.
35. Gordon T. Mortality experience among the Japanese in the United States, Hawaii and Japan. Public Health Rep 1957;72:543-553.
36. Berthold HK, Sudhop T, von Bergmann K Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism. A randomized controlled trial. JAMA 1998;279:1900-1902.
37. Neil HAW, Silagy CA, Lancaster T. Garlic powder in the treatment of moderate hyperlipidemia. J R Coll Physicians London 1996;30:329-334.
38. Jain AK, Vargas R, Gotzkowsky S, McMahon FG. Can garlic reduce levels of serum lipids? A controlled clinical study. Am J Med 1993;94:632-635.
39. Steiner M, Khan AH, Holvert D, Lin RI. A doble-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids. Am J Clin Nutr 1996;64:866-870.
40. Sainani GS, Desai DB, Gorke NH, Natu SM, Pise DV, Sanani PG. Effect of dietary garlic and onion on serum lipids profile in Jain community. Indian J Med Res 1979;69:776-780.
41. Keys A. Wine, garlic and CHD in seven countries. Lancet 1980;1:145-146.
42. Magyrar E. Incidence of coronary sclerosis and myocardial infarction in Hungary in the light of statistical data derived from autopsy material. Acta Med Acad Sci Hung. 1969;26:263-269.
43. Rotzsch W, Richter V, Rassoul F, and Walper A. Postprandiale Lipämie unter Medikation von Allium sativum. Kontrollierte Doppelblindstudie bei Probanden mit Erniedrigtem HDL2-cholesterin. Arzneimittelforschung 1992;42:1233-1237.
44. Kumar Rv, Banerji A, Kuurup CK, Ramasarna T. The nature of inhibition of 3-hydroxy-3-methylglutaryl CoA reductase by garlic-derived diallyl disulfide. Biochim Biophys Acta 1991; 1078:219-225.
45. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: Modifications of low density lipoproteins that increase its atherogenicity. N Engl J Med 1989;320:915-924.
46. Witzum J. Susceptibility of low density lipoprotein to oxidative modification. Am J Med 1993;94:347-349.
47. Ylä-Hertuala S. Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbits and man. J Clin Invest 1989;84:1086-1095.
48. Holvoet P, Collen D. Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J 1994;8:1279-1284.
49. Scherat TG, Siems WG, Brenke R, Behrends H, Jakstadt M, Conradi E, Grune T. Influence of a garlic extract on oxidative stress parameters in humans. In: Kumpulainen JT, Salonen JT, editors. Natural antioxidants and food quality in atherosclerosis and cancer prevention. Cambridge UK: The Royal Society of Chemistry. 1996:286-289.
50. Phelps S and Harris WS. Garlic supplementation and lipoprotein oxidation susceptibility. Lipids 1993 28:475-477.
51. Popov I, Blumstein A, Lewin G. Antioxidant effect of aqueous garlic extract. 1st communication: Direct detection using the photochemiluminescence. Arzneimittelforschung 1994;44:602-603.
52. Brady JF, Li H, Ishizaki H, Yang CS. Effect of diallyl sulfide on rat liver microsomal nitrosamine metabolism and other monoxygenase activities. Cancer Res 1988;48:5937-5940.
53. Maurya AK, Singh SV. Differential induction of glutathine transferase isoenzymes of mice stomach by diallyl sulfide, a naturally occurring anticarcinogen. Cancer Lett 1991;57:121-129.
54. Bordia A. Effects of garlic on human platelet aggregation in vitro. Atherosclerosis 1978;30:355-360.
55. Bordia A. Effect of garlic on blood lipids in patients with coronary heart disease. Am J Clin Nutr. 1981;34: 2100-2103.
56. Bordia A, Verma SK. Effect of garlic feeding on regression of experimental atherosclerosis in rabbits. Artery 1980;7:428-437.
57. Bordia AK, Bansai HC, Arora SK, Singh SV. Effects of the essential oils of garlic and onion on alimentary hyperlipemia. Atherosclerosis 1975;21:15-18.
58. Bordia AK, Joshi HK, Sandhya YK, Bhu N. Effects of essential oil of garlic on serum fibrinolylic activity in patients with coronary artery disease. Atherosclerosis 1978;28:155-159.
59. Bordia A, Sharma KD, Parmar YK, Verna SK. Protective effect of garlic oil on the changes produced by 3 weeks of fatty diet on serum cholesterol, serum triglycerides, fibrinolytic activity and platelet adhesivenness in man. Indian Heart J 1982;34:86-88.
60. Bordia AK, Sodhya SK, Rathore AS, Bhu N. Essential oil of garlic on blood lipids and fibrinolytic activity in patients with coronary artery disease. J Assoc Physicians India 1978;26:327-331.
61. Steiner M; Li MR. Changes in platelet function and susceptibility of lipoproteins to oxidation associated with administration of aged garlic extract. J Cardiovascular Pharmacology 1998;31:904-908.
62. Chutani SK, Bordia A. The effect of fried vs. raw garlic on fibrinolytic activity in man. Atherosclerosis 1981;38:417-21.
63. Legnani C, Frascaro M, Guazzaloca G, et al. Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects. Arzneimittelforschung 1993;43:119-122.
64. Al M, Bordia T, Mustafa T. Effect of raw versus boiled aqueous extract of garlic and onion on platelet aggregation. Protag Leukotr Ess Fatty Acids 1999;60:43-47.
65. Apitz-Castro R, Escalante J, Vargas R, Jain MK. Ajoene, the antiplatelet principle of garlic, synergistically potentials the antiaggregatory action of prostacyclin, for skolin, indomethacin and dypiridamole on human platelets. Thromb Res 1984;42, 303-311.
66. Apitz Castro R, Badimon JJ, Badimon L. A garlic derivative, ajoene, inhibits platelet deposition on severely damaged vessel wall in an in vivo porcine experimental model. Thromb Res 1994;75:246-249.
67. Makheja AN, Vvanderhoek J, Bailey JM. Inhibition of platelet aggregation and thromboxane synthesis by onion and garlic. Lancet, 1979;1:781.
68. Vanderhoek JY, Makheja AN, Bailey JM. Inhibition of fatty acid oxygenases by onion and garlic oils. Evidence for the mechanism by which these oils inhibit platelet aggregation. Biochem Pharmacol 1980;29:3169-3173.
69. Srivastava KC, Tyagi OD. Effect of garlic-derived principle (ajoene) on aggregation and arachidonic acid metabolism in human blood platelets. Prostag Leukotr Ess Fatty Acids 1993;49:587-595.
70. Apitz-Castro R, Cabrera S, Cruz M, Ledezma E, Jain MK. Effects of garlic extracts and three pure components isolated from it on human platelet aggregation, arachidonate metabolism, release reactivity and platelet ultrastructure. Thromb Res. 1983;32:155-169.
71. Ariga T, Oshiba S, Tamada T. Platelet aggregation inhibitor in garlic. Lancet 1981;1:150-151.
72. Lawson LD, Ramson DK, Hughes BG. Inhibition of whole blood platelet-aggregation by compounds in garlic cloce extracts and commercial garlic products. Thromb Res 1992;65:141-156.
73. Das I, Hirani J, Sooranna S. Arginine is not responsible for the activation of nitric oxide synthase by garlic. J Ethnopharmacol 1996;53:5-9.
74. Loeper M, Debray M. Hypotensive effect of tincture of garlic. Progr Med 1921;36:391-392.
75. Pekiov U. Plants with hypotensive, antiatheromatous, and coronary dilating action. Am J Chines Med 1979;7:197-236.
76. Rulfin J, Hunter SA. An evaluation of the side-effects of garlic as an antihypertensive agent. Cytobios 1983;37:85-89.
77. Kiesewetter H, Jung F, Pindur G, Jung FM, Mrowietz C, Wenzel E. Effect of garlic on trombocyte aggregation, microcirculation and other risk factors. Int J Clin Pharm Ther Toxicol 1991;29:151-155.
78. Martin N, Bardisa L, Pantoja C, Roman R, Vargas M. Experimental cardiovascular depressant effects of garlic (Allium sativum) dialysate. J Ethnopharmacol 1992;37:145-149.
79. McMahon FG, Vargas R. Can garlic lower blood pressure? A pilot study. Pharmacotherapy 1993,13:406-407.
80. Ozturk Y, Aydin S, Kosar M, Baser KH. Endothelium-dependent and independent effects of garlic on rat aorta. J Ethnopharmacol 1994;44:109-116.
81. Melzig MG, Krause E. Inhibition of adenosine deaminase activity of aortic endothelial cells by extracts of garlic (Allium sativum). Pharmazie 1995;50:359-361.
82. Das I, Khan NS, Sooranna SR. Potent activation of nitric oxide synthase by garlic: a basis for its therapeutic applications. Curr Med Res Opin 1995;13:257-263.
83. Rashid A, Hunter SA. The mechanism of hypotensive effects of garlic extract. JAMA 1985;35:357-362.
84. Dirch VM, Kiemer AK, Wagner H, Vollmar AM. Effect of allicin and ajoene, two compounds of garlic, on inducible nitric oxide syntase. Atherosclerosis 1998;139:33-339.
85. Breithaupt-Groger K, Ling M, Boudoulas H, Belz GG. Protective effect of chronic garlic intake on elastic properties of aorta in the elderly. Circulation 1997;96:2649-2655.
86. Orekhov AN, Grunwald J. Effects of garlic on atherosclerosis. Nutrition 1997;3:656-663.
87. Slater NGP. On garlic. Lancet 1979;1:1294.
88. Tyrell H. On garlic. Lancet 1979;1:129.